These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19920792)

  • 21. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [After diagnosis 11 more years remain. COPD alarm in Europe!].
    Wepner U
    MMW Fortschr Med; 2002 Oct; 144(44):12-3. PubMed ID: 12494590
    [No Abstract]   [Full Text] [Related]  

  • 23. Tiotropium and chronic obstructive pulmonary disease.
    McIvor RA
    BMJ; 2010 Feb; 340():c833. PubMed ID: 20172927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
    Rochat T; Janssens JP
    Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].
    Ohmura T; Nishikawa H
    Nihon Yakurigaku Zasshi; 2005 May; 125(5):307-13. PubMed ID: 15997169
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
    Singh S; Furberg CD
    Arch Intern Med; 2011 May; 171(10):920-2. PubMed ID: 21606097
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticholinergic treatment in airways diseases.
    Flynn RA; Glynn DA; Kennedy MP
    Adv Ther; 2009 Oct; 26(10):908-19. PubMed ID: 19967500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP
    Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photosensitive lichenoid eruption and inhaled tiotropium bromide.
    Pérez-Pérez L; Cabanillas M; Pereiro Ferreirós MM; Peteiro C; Toribio J
    Dermatology; 2007; 214(1):97-8. PubMed ID: 17191057
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular safety of tiotropium in patients with COPD.
    Celli B; Decramer M; Leimer I; Vogel U; Kesten S; Tashkin DP
    Chest; 2010 Jan; 137(1):20-30. PubMed ID: 19592475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.
    Hilleman DE; Malesker MA; Morrow LE; Schuller D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():253-63. PubMed ID: 19657399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern? A review of evidence from clinical trials.
    Sindi A; McIvor A
    Pol Arch Med Wewn; 2009; 119(1-2):74-8. PubMed ID: 19341182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL
    An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease.
    Yuan W; Nie S; Wang H; Xu Q; Jia N
    BMC Pulm Med; 2019 May; 19(1):88. PubMed ID: 31072407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term bronchodilator inhaled therapy in COPD: the role of tiotropium bromidum.
    Antoniu SA
    Rev Recent Clin Trials; 2009 May; 4(2):89-98. PubMed ID: 19463105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE; Khmel'kova NG; Belin-Atarac B
    Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tiotropium bromide in the treatment of chronic obstructive lung disease].
    Shmelev EI
    Ter Arkh; 2003; 75(12):69-72. PubMed ID: 14959476
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
    Tang Y; Massey D; Zhong NS
    Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-edged sword?
    Woodruff PG
    JAMA Intern Med; 2013 Jul; 173(13):1184-5. PubMed ID: 23689337
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of anticholinergics in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Med; 2004 Dec; 117 Suppl 12A():24S-32S. PubMed ID: 15693640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.